Neurizon inks $1.5M loan against R&D Tax Rebate
Neurizon Therapeutics (ASX:NUZ) retreated in intra-day trade on Wednesday after inking a non-dilutive loan agreement for $1.5 million to fund its current and future operations seeking to treat Huntington’s with its flagship drug NUZ-001.The funds in question are secured against it...
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
MUN | Ann: mFund - Monthly Redemption Report - MUN01 | 07/07/25 | 0 | 91 | |||
|
|||||||
MUN | Ann: mFund - Distribution - MUN01 | 02/07/25 | 0 | 125 | |||
|
|||||||
MUN | Ann: mFund - Monthly Redemption Report - MUN01 | 05/06/25 | 0 | 141 | |||
|
|||||||
MUN | Ann: mFund - Removal from Settlement Service - MUN01 | 30/05/25 | 0 | 109 | |||
|
|||||||
MUN | Ann: mFund - Removal from Settlement Service - MUN01 | 29/05/25 | 0 | 142 | |||
|
|||||||
MUN | Ann: mFund - Monthly Redemption Report - MUN01 | 07/05/25 | 0 | 115 | |||
|
|||||||
MUN | Ann: mFund - Monthly Redemption Report - MUN01 | 07/04/25 | 0 | 142 | |||
|
|||||||
MUN | Ann: Half Yearly Financial Statements - MUN01 | 13/03/25 | 0 | 161 | |||
|
See All Discussions
Timeline
![]() |
|
||||
![]() |
|
||||
![]() |
|
||||
![]() |
|
||||
![]() |
|
||||
![]() |
|
||||
View More |